Description
An oxazolidinone-type antibiotic; has activity against a panel of C. difficile strains (MICs = 0.125-0.5 μg/ml); inhibits toxin A and B formation in stationary-phase cultures and spore formation in late exponential cultures of the toxigenic C. difficile strain ATCC 9689; inhibits C. difficile protein synthesis (IC50s = 0.08-0.31 μg/ml); increases survival in a mouse model of CDAD at 1 and 10 mg/kg; increases survival in a hamster model of CDAD at >3 mg/kg
Formal name: 1-cyclopropyl-6-fluoro-7-[4-[[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-3-oxazolidinyl]phenoxy]methyl]-4-hydroxy-1-piperidinyl]-1-4-dihydro-4-oxo-3-quinolinecarboxylic acid
Synonyms: ACT-179811
Molecular weight: 585.6
CAS: 1025097-10-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics|Oxazolidinones||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases